A detailed history of Black Rock Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,282,430 shares of AMRX stock, worth $102 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,282,430
Previous 9,164,172 23.11%
Holding current value
$102 Million
Previous $55.5 Million 29.01%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.36 - $7.11 $11.4 Million - $15.1 Million
2,118,258 Added 23.11%
11,282,430 $71.6 Million
Q1 2024

May 10, 2024

BUY
$5.24 - $6.34 $1.67 Million - $2.01 Million
317,751 Added 3.59%
9,164,172 $55.5 Million
Q4 2023

Feb 13, 2024

BUY
$3.36 - $6.21 $2.73 Million - $5.05 Million
813,912 Added 10.13%
8,846,421 $53.7 Million
Q3 2023

Nov 13, 2023

BUY
$2.76 - $4.59 $67,655 - $112,514
24,513 Added 0.31%
8,032,509 $33.9 Million
Q2 2023

Aug 11, 2023

BUY
$1.33 - $3.1 $1.04 Million - $2.41 Million
778,523 Added 10.77%
8,007,996 $24.8 Million
Q1 2023

May 12, 2023

SELL
$1.27 - $2.7 $85,280 - $181,305
-67,150 Reduced 0.92%
7,229,473 $10 Million
Q4 2022

Feb 13, 2023

BUY
$1.96 - $2.61 $461,025 - $613,916
235,217 Added 3.33%
7,296,623 $14.5 Million
Q3 2022

Nov 14, 2022

SELL
$2.02 - $3.62 $795,871 - $1.43 Million
-393,996 Reduced 5.28%
7,061,406 $14.3 Million
Q2 2022

Aug 12, 2022

BUY
$3.01 - $4.46 $1.12 Million - $1.66 Million
372,700 Added 5.26%
7,455,402 $23.7 Million
Q1 2022

May 12, 2022

BUY
$3.9 - $4.89 $355,180 - $445,342
91,072 Added 1.3%
7,082,702 $29.5 Million
Q4 2021

Feb 10, 2022

BUY
$3.95 - $5.85 $176,726 - $261,734
44,741 Added 0.64%
6,991,630 $33.5 Million
Q3 2021

Nov 09, 2021

SELL
$4.31 - $5.64 $633,302 - $828,730
-146,938 Reduced 2.07%
6,946,889 $37.1 Million
Q2 2021

Aug 11, 2021

BUY
$5.12 - $6.82 $36.3 Million - $48.4 Million
7,093,827 New
7,093,827 $36.3 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.37B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.